EI
AMAG

EAM Investors’s AMAG Pharmaceuticals AMAG Stock Holding History

EAM Investors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-69,434
Closed -$4.79M – 369
2015
Q2 		$4.79M Sell
69,434
-4,279
-6% -$269K 0.56% 33
2015
Q1 		$4.03M Sell
73,713
-22,845
-24% -$1.09M 0.47% 46
2014
Q4 		$4.12M Buy
96,558
+8,692
+10% +$314K 0.57% 23
2014
Q3 		$2.8M Buy
+87,866
New +$1.87M 0.57% 25
2014
Q1 		– Sell
-46,744
Closed -$1.13M – 374
2013
Q4 		$1.13M Buy
+46,744
New +$1.1M 0.2% 280

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors's AMAG Position: Q3 2015 in Review

EAM Investors sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 69,434 shares — an estimated $4.79M sold.

EAM Investors first reported a position in AMAG in Q4 2013 and held it in 5 quarters. The position peaked at $4.79M in Q2 2015. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

  • EAM Investors reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • EAM Investors sold 69,434 AMAG Pharmaceuticals shares in Q3 2015, an estimated $4.79M.
  • EAM Investors first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • EAM Investors's AMAG Pharmaceuticals position peaked at $4.79M in Q2 2015.
  • 210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on EAM Investors's 13F filing for Q3 2015, filed 6 Nov 2015.